• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质细胞招募并调节调节性T细胞。

Mesenchymal cells recruit and regulate T regulatory cells.

作者信息

Di Ianni Mauro, Del Papa Beatrice, De Ioanni Maria, Moretti Lorenzo, Bonifacio Elisabetta, Cecchini Debora, Sportoletti Paolo, Falzetti Franca, Tabilio Antonio

机构信息

Hematology and Clinical Immunology Section, Department of Clinical and Experimental Medicine, University of Perugia, Italy.

出版信息

Exp Hematol. 2008 Mar;36(3):309-18. doi: 10.1016/j.exphem.2007.11.007.

DOI:10.1016/j.exphem.2007.11.007
PMID:18279718
Abstract

OBJECTIVE

Despite much investigation into T regulatory cells (Tregs), little is known about the mechanism controlling their recruitment and function. Because multipotent mesenchymal stromal cells (MSCs) exert an immune regulatory function and suppress T-cell proliferation, this in vitro study investigated their role in Treg recruitment and function.

MATERIALS AND METHODS

Human MSCs and different T cell populations (CD3(+), CD3(+)/CD45RA(+), CD3(+)/CD45RO(+), CD4(+)/CD25(+), CD4(+)/CD25(+)/CD45RO(+), CD4(+)/CD25(+)/CD45RA(+)) from healthy donors were cocultured for up to 15 days. Harvested lymphocytes were analyzed by flow cytometry and FoxP3 and CD127 expressions were measured by real-time polymerase chain reaction. Their regulatory activity was assessed.

RESULTS

We demonstrate MSC recruit Tregs from a fraction of CD3(+) and from immunoselected CD3(+)/CD45RA(+) and CD3(+)/CD45RO(+) fractions. After culture with MSCs both immunoselected fractions registered increases in the CD4(+)/CD25(bright)/FoxP3 subset and CD127 expression was downregulated. When purified Treg populations (CD4/CD25(+), CD4/CD25(+)/CD45RA(+), and CD4/CD25(+)/CD45RO(+)) are used in MSC cocultures, they maintain FoxP3 expression and CD127 expression is downregulated. Treg suppressive capacity was maintained in Treg populations that were layered on MSC for up to 15 days while control Tregs lost all suppressive activity after 5 days culture.

CONCLUSIONS

In conclusion, our study demonstrates that MSCs recruit, regulate, and maintain T-regulatory phenotype and function over time.

摘要

目的

尽管对调节性T细胞(Tregs)进行了大量研究,但对控制其募集和功能的机制仍知之甚少。由于多能间充质基质细胞(MSCs)发挥免疫调节功能并抑制T细胞增殖,本体外研究探讨了它们在Treg募集和功能中的作用。

材料与方法

将来自健康供体的人MSCs与不同的T细胞群体(CD3(+)、CD3(+)/CD45RA(+)、CD3(+)/CD45RO(+)、CD4(+)/CD25(+)、CD4(+)/CD25(+)/CD45RO(+)、CD4(+)/CD25(+)/CD45RA(+))共培养长达15天。通过流式细胞术分析收获的淋巴细胞,并通过实时聚合酶链反应测量FoxP3和CD127的表达。评估它们的调节活性。

结果

我们证明MSCs从一部分CD3(+)以及免疫选择的CD3(+)/CD45RA(+)和CD3(+)/CD45RO(+)部分募集Tregs。与MSCs共培养后,两个免疫选择部分中CD4(+)/CD25(bright)/FoxP3亚群均增加,且CD127表达下调。当将纯化的Treg群体(CD4/CD25(+)、CD4/CD25(+)/CD45RA(+)和CD4/CD25(+)/CD45RO(+))用于与MSCs共培养时,它们维持FoxP3表达,且CD127表达下调。在MSCs上分层培养长达15天的Treg群体中,Treg抑制能力得以维持,而对照Tregs在培养5天后失去了所有抑制活性。

结论

总之,我们的研究表明MSCs随着时间的推移募集、调节并维持T调节表型和功能。

相似文献

1
Mesenchymal cells recruit and regulate T regulatory cells.间充质细胞招募并调节调节性T细胞。
Exp Hematol. 2008 Mar;36(3):309-18. doi: 10.1016/j.exphem.2007.11.007.
2
A modified flow cytometry method for objective estimation of human CD4 regulatory T cells (CD4 Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling.一种改良的流式细胞术方法,通过 CD4/CD25/CD45RO/FoxP3 标记,客观估计外周血中的人 CD4 调节性 T 细胞(CD4 Tregs)。
Cytometry B Clin Cytom. 2020 May;98(3):259-269. doi: 10.1002/cyto.b.21841. Epub 2019 Sep 30.
3
Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells.人脂肪组织来源的间充质基质细胞抑制 CD4+T 细胞增殖,并诱导调节性 T 细胞以及 CD4+CD25+T 细胞上的 CD127 表达。
Cells. 2021 Jan 1;10(1):58. doi: 10.3390/cells10010058.
4
Reduced frequency and functional defects of CD4CD25CD127 regulatory T cells in patients with unexplained recurrent spontaneous abortion.原因不明复发性自然流产患者中 CD4+CD25+CD127-调节性 T 细胞频率降低和功能缺陷。
Reprod Biol Endocrinol. 2020 Jun 10;18(1):62. doi: 10.1186/s12958-020-00619-7.
5
Induction of CD4CD25FOXP3 regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation.间充质干细胞诱导 CD4CD25FOXP3 调节性 T 细胞与泛素化因子的调节和 TSDR 去甲基化有关。
Stem Cell Res Ther. 2018 Oct 25;9(1):273. doi: 10.1186/s13287-018-0991-1.
6
Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.与活化单核细胞的相互作用可增强人CD4+CD45ro+CD25+CD127(低表达)调节性T细胞的细胞因子表达和抑制活性。
Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.
7
Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis.慢性类风湿关节炎患者外周血 CD45RA+ 和 CD45RO+ CD4+CD25+CD127(low) Treg 细胞的表型、功能和基因表达谱分析。
Arthritis Rheumatol. 2016 Jan;68(1):103-16. doi: 10.1002/art.39408.
8
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.间充质干细胞在Th1和Th17细胞分化过程中产生CD4+CD25+Foxp3+调节性T细胞群体。
Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216.
9
Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.未经治疗的溃疡性结肠炎患者中,具有受损抑制功能的CD4(+) CD25(+) CD127(低) FoxP3(+)调节性T细胞减少。
Autoimmunity. 2015;48(8):556-61. doi: 10.3109/08916934.2015.1070835. Epub 2015 Aug 31.
10
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.TNFR2 和 CD25 的共表达在人外周血中鉴定出更多的功能性 CD4+FOXP3+调节性 T 细胞。
Eur J Immunol. 2010 Apr;40(4):1099-106. doi: 10.1002/eji.200940022.

引用本文的文献

1
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients.新冠病毒病的非病毒疗法:我们目前的进展如何?我们在新冠病毒病方面的经验如何有助于我们为长期新冠患者开发细胞疗法。
Biomedicines. 2025 Jul 23;13(8):1801. doi: 10.3390/biomedicines13081801.
2
Molecular and Cellular Mechanisms of the Therapeutic Effect of Mesenchymal Stem Cells and Extracellular Vesicles in Corneal Regeneration.间质干细胞和细胞外囊泡在角膜再生治疗效果的分子和细胞机制。
Int J Mol Sci. 2024 Oct 16;25(20):11121. doi: 10.3390/ijms252011121.
3
How to enhance MSCs therapeutic properties? An insight on potentiation methods.
如何增强间充质干细胞的治疗特性?增强方法的新视角。
Stem Cell Res Ther. 2024 Sep 27;15(1):331. doi: 10.1186/s13287-024-03935-6.
4
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies.配备齐全的嵌合抗原受体(CARs)可解决肿瘤异质性问题,增强安全性,并提高细胞免疫疗法的功能。
Front Immunol. 2024 Jun 3;15:1407992. doi: 10.3389/fimmu.2024.1407992. eCollection 2024.
5
Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.间充质干细胞在白血病中的生物学特性与治疗特性
Int J Mol Sci. 2024 Feb 21;25(5):2527. doi: 10.3390/ijms25052527.
6
Regulatory T lymphocytes in traumatic brain injury.创伤性脑损伤中的调节性 T 淋巴细胞。
Neurochem Int. 2024 Feb;173:105660. doi: 10.1016/j.neuint.2023.105660. Epub 2023 Dec 25.
7
Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure.间充质干细胞在急性肝衰竭潜在治疗中的应用的分离、培养和传递考虑因素。
Front Immunol. 2023 Sep 7;14:1243220. doi: 10.3389/fimmu.2023.1243220. eCollection 2023.
8
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche.工程化串联 CD33xCD146 CAR CIK(细胞因子诱导的杀伤)细胞以靶向急性髓系白血病龛。
Front Immunol. 2023 May 25;14:1192333. doi: 10.3389/fimmu.2023.1192333. eCollection 2023.
9
Regulatory T-Cell Enhancement, Expression of Adhesion Molecules, and Production of Anti-Inflammatory Factors Are Differentially Modulated by Spheroid-Cultured Mesenchymal Stem Cells.球体培养的间充质干细胞对调节性 T 细胞的增强、黏附分子的表达和抗炎因子的产生具有不同的调节作用。
Int J Mol Sci. 2022 Nov 18;23(22):14349. doi: 10.3390/ijms232214349.
10
Regenerative medicine technologies applied to transplant medicine. An update.应用于移植医学的再生医学技术。最新进展。
Front Bioeng Biotechnol. 2022 Sep 28;10:1015628. doi: 10.3389/fbioe.2022.1015628. eCollection 2022.